Centiva Capital’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Centiva Capital’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-267,595	Closed	-$2.62M	–	1978
2022 Q2	$2.62M	Buy	267,595 +7,600	+3%	+$74.5K	0.06%	287
2022 Q1	$2.54M	Buy	259,995 +9,995	+4%	+$97.2K	0.05%	353
2021 Q4	$2.43M	Buy	+250,000	New	+$2.43M	0.05%	325

Other funds holding MSAC

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Centiva Capital's MSAC Position: Q3 2022 in Review

Centiva Capital sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2022, closing a stake of 267,595 shares — an estimated $2.62M sold.

Centiva Capital first reported a position in MSAC in Q4 2021 and held it in 3 quarters. The position peaked at $2.62M in Q2 2022. 53 funds tracked by Wall St. Rank hold MSAC as of Q3 2022.

Centiva Capital reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
Centiva Capital sold 267,595 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2022, an estimated $2.62M.
Centiva Capital first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
Centiva Capital's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.62M in Q2 2022.
53 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.